Rankings
▼
Calendar
DSGN Q1 2025 Earnings — Design Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DSGN
Design Therapeutics, Inc.
$569M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$20M
Net Income
-$18M
EPS (Diluted)
$-0.31
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$17M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$237M
Total Liabilities
$10M
Stockholders' Equity
$228M
Cash & Equivalents
$14M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$143,000
+100.0%
Operating Income
-$20M
-$14M
-41.8%
Net Income
-$18M
-$11M
-59.5%
← FY 2025
All Quarters
Q2 2025 →